Tag: Combination treatment may extend late-stage breast cancer survival

Combination treatment may extend late-stage breast cancer survival

October 23, 2018

A recent trial proposes combining a specific drug with hormone therapy to extend the survival of some women with advanced breast cancer. The study showed that women who received palbociclib and hormone therapy lived up to 10 months longer than those given hormone treatment alone. It also delayed the time at which women needed to […]

Continue Reading